關鍵數據
6.670今開
6.790最高
84.38K成交量
虧損本益比TTM
6.57本益比動
--股利TTM
0.31%換手率
6.650昨收
6.600最低
391.12K成交額
虧損本益比靜
5.72市淨率
0.00%股息率 TTM
-10.86%ROA
9.55552週最高
1.55量比
-14.67M淨利潤
27.14M總股本
-0.3681每股盈餘TTM
1.08Beta
-36.61%ROE
4.31052週最低
2.86%振幅
61.58%毛利率
183.60M總市值
-1.93回報/風險
3.36%風險率
最新
電話會議紀要

即將為您帶來更多新聞,敬請期待。 。 。
Journey Medical Corp評分
0.12與上次評分對比預測8.00
財務診斷7.99
技術分析4.35
公司估值8.78
機構認同度5.00
風險評估3.91
分析師評級
買入評級
13.500目標均價
+109.63%漲幅空間
Journey Medical Corp 最新財報電話會記錄
Journey Medical (DERM) 2026 年第二季財報電話會議:Emrosi 帶動營收成長 23%
Journey Medical 的 2026 年第二季財報電話會議內容涵蓋 23% 的營收成長、Emrosi 處方量加速增長、調整後 EBITDA 呈正數,以及保險給付涵蓋範圍的改善。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Journey Medical Corp 簡介
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
行業藥品
公司代碼DERM
員工數量41
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Fortress Biotech Inc | 15.74% |
|---|
| Maraoui (Claude) | 10.73% |
|---|
| Wasatch Global Investors Inc | 9.99% |
|---|
| Tang Capital Management, LLC | 8.69% |
|---|
| 股東類型 | 佔比 |
|---|
| Hedge Fund | 21.80% |
|---|
| Investment Advisor/Hedge Fund | 17.26% |
|---|
| Individual Investor | 16.85% |
|---|
| Investment Advisor | 16.39% |
|---|
常見問題
Journey Medical Corp(DERM)的當前股價是多少?
Journey Medical Corp(DERM)的當前股價是 6.64。
Journey Medical Corp 的股票代碼是什麼?
Journey Medical Corp的股票代碼是DERM。
Journey Medical Corp股票的52週最高點是多少?
Journey Medical Corp股票的52週最高點是9.55。
Journey Medical Corp股票的52週最低點是多少?
Journey Medical Corp股票的52週最低點是4.31。
Journey Medical Corp的市值是多少?
Journey Medical Corp的市值是180.24M。
現在Journey Medical Corp(DERM)的股票是買入、持有還是賣出?
根據分析師評級,Journey Medical Corp(DERM)的總體評級為買入,目標價格為13.50。
Journey Medical Corp(DERM)股票的每股收益(EPS TTM)是多少
Journey Medical Corp(DERM)股票的每股收益(EPS TTM)是-0.37。